Vivo Opportunity Fund, L.P. (CIK 0001726403)

Latest company ownership

Shares held
3,158,851
Last filed at
Jul 21, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
168,165
Last filed at
Mar 11, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4
Shares held
50,282
Last filed at
Feb 9, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
5,655
Last filed at
Feb 9, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 9, 2021 Feb 9, 2021 Bolt Biotherapeutics, Inc. 10% Owner Buy 96.3 +349,774 9.93% ✗ $7M
Feb 9, 2021 Feb 9, 2021 Terns Pharmaceuticals, Inc. 10% Owner Buy 100.0 +475,000 21.59% ✗ $8.1M
Jul 21, 2020 Jul 21, 2020 ALX ONCOLOGY HOLDINGS INC 10% Owner Buy 100.0 +975,000 100.00% ✗ $18.5M
Mar 9, 2020 Mar 11, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 51.3 -528 -0.02% ✗ $10.3K
Feb 7, 2020 Feb 11, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 37.5 -13,460 -0.21% ✗ $291.6K
Feb 4, 2020 Feb 6, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 37.5 -13,460 -0.41% ✗ $306.9K
Jan 29, 2020 Jan 31, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 37.5 -26,920 -0.27% ✗ $594.2K
Mar 20, 2019 Mar 25, 2019 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 16.3 -417,000 -11.16% ✗ $9.3M
Jul 20, 2018 Jul 20, 2018 Crinetics Pharmaceuticals, Inc. 10% Owner Buy 100.0 +353,180 10.02% ✗ $6.6M